A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays

46Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A new method for amplification and labeling of RNA is assessed that permits gene expression microarray analysis of formalin-fixed paraffin-embedded tissue (FFPET) samples. Valid biological data were obtained using gene expression microarrays of diffuse large B-cell lymphoma (DLBCL) FFPET samples. We examined 59 matched DLBCL patient samples, FFPET, and fresh/frozen. The samples contained both prognostic subgroups of DLBCL: germinal center B-cell (GCB) and activated B-cell (ABC). Fresh/frozen (FF) samples were amplified by both the traditional Eberwine oligo-dT method and a new method described herein. The matching FFPET samples were also amplified using the new method. Here we detail the comparison of results from all three datasets of matched samples. An established classification model built from previous data accurately classified these new samples. This new method provides a useful technology advance for microarray analysis of FFPET archival samples. Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology.

Cite

CITATION STYLE

APA

Williams, P. M., Li, R., Johnson, N. A., Wright, G., Heath, J. D., & Gascoyne, R. D. (2010). A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays. Journal of Molecular Diagnostics, 12(5), 680–686. https://doi.org/10.2353/jmoldx.2010.090164

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free